深度学习自动分割助力宫颈癌自适应放疗在线剂量优化
本研究评估深度学习模型自动分割宫颈癌靶区与危及器官,以支持每日在线剂量优化、免除内靶区扩边并降低调强放疗毒性。2D DeepLabV3+与3D Unet在内部和外部测试集上分割表现相近,靶区剂量覆盖达到EMBRACE II协议要求,为自动在线剂量优化提供依据。
要点
- 2D与3D模型在内部和外部测试集上分割表现相近。
- 靶区平均DSC内部0.88/0.87,外部0.81/0.82。
- 内部测试集靶区V42.75 Gy>98%的扫描比例2D为98%、3D为91%。
核心结论
- 深度学习模型可在两家机构数据上以相近性能自动分割宫颈解剖结构。
- 在较小靶区与淋巴结计划靶区边距下,自动分割轮廓的剂量学精度合理,为先进自适应放疗的自动在线剂量优化铺路。
研究设计与样本
- 研究在408例CT扫描上勾画宫颈-子宫、阴道、宫旁、膀胱、直肠、乙状结肠、股骨头、肾脏、脊髓和肠袋。
- 数据来自MD Anderson癌症中心(n=214)、Polyclinique Bordeaux Nord Aquitaine(n=30)及医学图像计算与计算机辅助干预挑战赛(n=3)。
- 数据分为255例训练、61例验证、62例内部测试和30例外测试CT扫描。
- 研究评估2D DeepLabV3+(Google)与3D Unet(RayStation,RaySearch Laboratories)两种模型。
- 在内部和外部测试集每例CT上分别基于手动、2D模型或3D模型分割生成三套调强放疗计划。
主要发现
- 验证集、内部测试集和外部测试集所有器官平均DSC:2D模型分别为0.67-0.96、0.71-0.97、0.42-0.92;3D模型分别为0.66-0.96、0.70-0.97、0.37-0.93。
- 内部测试集和外部测试集靶区平均DSC:2D模型分别为0.88和0.81;3D模型分别为0.87和0.82。
- 外部测试集靶区间观察者变异性平均(范围)DSC为0.85(0.77-0.90)。
- 内部测试集基于2D和3D模型轮廓的剂量使靶区V42.75 Gy>98%的CT扫描比例分别为98%和91%。
- 外部测试集该比例分别升至2D模型的100%和3D模型的93%。
关键数值与推荐
- 剂量约束遵循EMBRACE II协议,靶区和淋巴结计划靶区边距分别缩小至5 mm和3 mm。
- 几何差异采用Dice相似系数、距离一致性和Hausdorff距离评估。
- 剂量差异采用手动轮廓上的临床指标和伽马指数评估。
临床怎么用
- 自动分割可用于宫颈癌自适应放疗的在线剂量优化流程,减少对内靶区扩边的依赖。
- 2D与3D模型分割性能相近,在较小计划靶区边距下剂量学精度合理,可支持自动在线剂量优化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: This study investigated deep learning models for automatic segmentation to support the development of daily online dose optimization strategies, eliminating the need for internal target volume expansions and thereby reducing toxicity events of intensity modulated radiation therapy for cervical cancer. METHODS AND MATERIALS: The cervix-uterus, vagina, parametrium, bladder, rectum, sigmoid, femoral heads, kidneys, spinal cord, and bowel bag were delineated on 408 computed tomography (CT) scans from patients treated at MD Anderson Cancer Center (n = 214), Polyclinique Bordeaux Nord Aquitaine (n = 30), and enrolled in a Medical Image Computing & Computer Assisted Intervention challenge (n = 3). The data were divided into 255 training, 61 validation, 62 internal test, and 30 external test CT scans. Two models were investigated: the 2-dimensional (2D) DeepLabV3+ (Google) and 3-dimensional (3D) Unet in RayStation (RaySearch Laboratories). Three intensity modulated radiation therapy plans were generated on each CT of the internal and external test sets using either the manual, 2D model, or 3D model segmentations. The dose constraints followed the External beam radiochemotherapy and MRI based adaptive BRAchytherapy in locally advanced CErvical cancer (EMBRACE) II protocol, with reduced margins of 5 and 3 mm for the target and nodal planning target volume. Geometric discrepancies between the manual and predicted contours were assessed using the Dice similarity coefficient (DSC), distance-to-agreement, and Hausdorff distance. Dosimetric discrepancies between the manual and model doses were assessed using clinical indices on the manual contours and the gamma index. Interobserver variability was assessed for the cervix-uterus, parametrium, and vagina for the definition of the primary clinical target volume (CTVT) on the external test set. RESULTS: Average DSCs across all organs were 0.67 to 0.96, 0.71 to 0.97, and 0.42 to 0.92 for the 2D model and 0.66 to 0.96, 0.70 to 0.97, and 0.37 to 0.93 for the 3D model on the validation, internal, and external test sets. Average DSCs of the CTVT were 0.88 and 0.81 for the 2D model and 0.87 and 0.82 for the 3D model on the internal and external test sets. Interobserver variability of the CTVT corresponded to a mean (range) DSC of 0.85 (0.77-0.90) on the external test set. On the internal test set, the doses from the 2D and 3D model contours provided a CTVT V42.75 Gy >98% for 98% and 91% of the CT scans, respectively. On the external test set, these percentages were increased to 100% and 93% for the 2D and 3D models, respectively. CONCLUSIONS: The investigated models provided auto-segmentation of the cervix anatomy with similar performances on 2 institutional data sets and reasonable dosimetric accuracies using small planning target volume margins, paving the way to automatic online dose optimization for advanced adaptive radiation therapy strategies.
引用
- Rigaud B, Anderson BM, Yu ZH, et al. Automatic Segmentation Using Deep Learning to Enable Online Dose Optimization During Adaptive Radiation Therapy of Cervical Cancer. Int J Radiat Oncol Biol Phys. 2020. PMID: 33181248. doi:10.1016/j.ijrobp.2020.10.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。